Altamira Therapeutics Ltd... (CYTO)
undefined
undefined%
At close: undefined
0.43
-2.14%
After-hours Dec 13, 2024, 03:20 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Revenue - 305.62K 63.88K 174.47K -56.00K 1.27M 322.00K -414.00K -67.00K 3.01M - -
Cost of Revenue - 1.44M 2.24M - - - - - - - - -
Gross Profit - -1.14M -2.18M 174.47K -56.00K 1.27M 322.00K -414.00K -67.00K 3.01M - -
Operating Income -5.92M -26.13M -17.10M -5.28M -7.26M -10.95M -24.36M -30.22M -30.88M -22.19M -14.62M -4.61M
Interest Income 730.20K 969.00 3.22K 258.00 17.88K - 53.57K 67.56K 37.00K 52.13K 74.04K 5.83K
Pretax Income -7.27M -26.54M -17.37M -8.22M -6.83M -11.33M -24.43M -30.79M -29.70M -18.18M -14.70M -4.60M
Net Income -7.27M -26.53M -17.39M -8.20M -6.63M -11.50M -24.41M -30.66M -29.70M -18.18M -15.00M -4.60M
Selling & General & Admin 3.12M 5.90M 6.39M 2.59M 3.93M 4.26M 5.15M 5.41M 4.34M 4.49M 1.31M 589.53K
Research & Development 3.04M 19.68M 8.94M 2.86M 3.33M 6.69M 19.21M 24.78M 26.54M 17.70M 13.25M 3.99M
Other Expenses - -586.73K -409.93K - - 215.72K 87.59K 34.05K 62.20K 73.43K 49.42K 34.28K
Operating Expenses 6.54M 24.99M 14.92M 5.46M 7.26M 10.95M 24.36M 30.22M 30.88M 22.19M 14.62M 4.61M
Interest Expense - 911.87K 189.69K 135.15K 28.63K 1.07M 1.64M 828.55K 8.00K 49.63K 50.18K -
Selling & Marketing Expenses 15.35K 2.38M 1.50M 95.66K 113.96K 43.82K 199.48K 45.65K 72.56K 237.72K 479.03K 86.23K
Cost & Expenses 6.54M 26.44M 17.16M 5.46M 7.26M 10.95M 24.36M 30.22M 30.88M 22.19M 14.62M 4.61M
Income Tax - -10.33K 21.62K -21.28K -193.84K 162.18K -17.77K -131.06K -84.78K -892.18K 305.75K -
Shares Outstanding (Basic) 491.00K 45.54K 33.12K 15.04K 14.54K 3.98K 1.09K 858.20 807.40 692.30 451.30 451.30
Shares Outstanding (Diluted) 491.26K 45.54K 33.12K 15.04K 14.54K 3.98K 1.09K 858.20 807.40 692.30 451.30 451.30
EPS (Basic) -14.81 -582.58 -525.13 -545.41 -455.96 -2.89K -22.32K -35.73K -36.79K -26.27K -33.25K -10.20K
EPS (Diluted) -14.8 -582.58 -525.13 -545.41 -455.96 -2.89K -22.32K -35.73K -36.79K -26.27K -33.25K -10.20K
EBITDA -1.35M -17.64M -6.72M -5.26M -7.24M -10.95M -24.31M -30.06M -30.84M -22.19M -14.51M -4.60M
Depreciation & Amortization 5.92M 118.89K 76.36K 20.04K 30.82K 72.71K 122.78K 97.60K 92.78K 73.98K 37.52K 9.24K